# Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer

> **NCT00553345** · PHASE3 · UNKNOWN · sponsor: **University of Birmingham** · enrollment: 515 (—)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** selenium
- **DRUG:** vitamin E
- **PROCEDURE:** chemoprevention

## Key facts

- **NCT ID:** NCT00553345
- **Lead sponsor:** University of Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 515 (—)
- **Last updated:** 2014-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00553345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00553345, "Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00553345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*